Pinegrove Venture Partners, LLC

SVB Capital Management, LLC is an investment advisory entity within the SVB Capital platform, historically affiliated with SVB Financial Group and Silicon Valley Bank. Based in Santa Clara, California, SVB Capital operates as a specialist in venture capital and growth equity, managing a family of funds that invest in venture partnerships and directly in high-growth technology and life sciences companies. SVB Capital Management, LLC provides discretionary management for these vehicles and related accounts, focusing on innovation-driven businesses across the global venture ecosystem. The platform’s primary activities are in private markets—fund-of-funds commitments to top-tier venture and growth managers, secondaries, and direct and co-investments in venture-backed companies. As a result, most of the capital overseen by SVB Capital Management, LLC is deployed in illiquid private positions rather than listed securities. However, when portfolio companies go public or certain secondary or structured transactions involve publicly traded instruments, the adviser may hold reportable U.S.-listed equities. SVB Capital Management, LLC appears in U.S. regulatory records as an institutional investment manager under CIK #0002011811 and files quarterly Form 13F. These filings disclose the long U.S. equity and equity-linked positions over which it has investment discretion at quarter-end—typically stakes in former private portfolio companies that have completed IPOs, direct listings, or de-SPAC transactions. On an advanced 13F analytics platform, this limited public data can be assembled into a manager-specific Historical Track Record, normalized to a user-defined starting notional, to study the behavior of the visible U.S. equity sleeve across different market regimes.

SVB Capital Management, LLC’s core mandate is venture capital and growth equity, not traditional public equity stock picking. The investment program is built around three pillars: - Venture fund-of-funds: Commitments to early-stage, multi-stage, and sector-focused venture funds, providing diversified exposure to thousands of portfolio companies through relationships with leading GPs. - Secondaries: Purchases of interests in existing venture funds and portfolios of direct venture-backed positions, often from liquidity-seeking LPs or corporate sellers. - Direct and co-investments: Participation alongside lead venture and growth funds in later-stage and expansion financings of high-conviction companies, typically in software, fintech, infrastructure, consumer internet, and life sciences tools and services. Within this framework, U.S.-listed holdings arise primarily as a lifecycle outcome: - Portfolio companies that list on U.S. exchanges generate tradable shares that SVB Capital Management, LLC may hold beyond lock-up to capture further compounding or to stage exits. - Secondary and structured deals may involve public components, such as blocks of stock in recently listed venture-backed companies. The resulting U.S. equity book, as reflected in 13F Portfolio Composition, tends to exhibit: - A concentrated set of positions in venture-backed technology and healthcare names, often mid-cap growth companies with strong unit economics and large addressable markets. - Minimal use of broad index ETFs; exposures are overwhelmingly company-specific and linked to earlier private theses. - Long holding periods, consistent with a venture-style horizon, with reductions driven by liquidity events, valuation discipline, and fund-life considerations rather than by short-term factor views. Because SVB Capital’s edge lies in sourcing, underwriting, and supporting venture-backed businesses, the 13F-reported equities should be viewed as a public tail on a predominantly private portfolio rather than as an independent long-only equity strategy.

SVB Capital Management, LLC is best understood as the advisory entity for a venture and growth-equity platform whose primary activities are in private markets. Its 13F filings under CIK #0002011811 reveal only the U.S.-listed component of that ecosystem: a concentrated, growth-oriented portfolio of venture-backed companies that have transitioned into public markets, reflecting legacy private theses rather than a separate public equity mandate. For allocators and researchers, the most useful insights come from systematic, holdings-based interrogation of the 13F data. Examining changes in 13F Portfolio Composition through time—such as shifts in exposure across software, fintech, infrastructure, and life sciences, and the evolution of position sizes as IPOs season and shares are distributed—can illuminate how SVB Capital paces and scales its public exposure. By running a Portfolio Simulator or other Performance Backtests Online on these disclosures, users can derive a normalized Historical Track Record, overlay the evolving Volatility Profile, and estimate an implied Sharpe Ratio for the disclosed U.S. sleeve. The central diagnostic question is how dynamically SVB Capital Management, LLC adjusts its public holdings—by sector mix, single-name concentration, and pace of exit—as regimes rotate between liquidity-rich, growth-led markets and more challenging environments marked by higher discount rates, tighter funding conditions, and factor rotations away from high-multiple innovation names, and how clearly those adjustments are reflected in the capital trajectory implied by its reported holdings.

The risk profile implied by SVB Capital Management, LLC’s disclosed U.S. holdings is that of a concentrated, sector-focused growth investor operating at the intersection of private and public markets. Several key risk dimensions are worth highlighting: - Sector and thematic concentration: Positions are heavily tilted toward technology, software, fintech, and life sciences, often in companies with long-duration growth profiles. This creates sensitivity to valuation regimes for growth stocks, changes in discount rates, and investor appetite for innovation. - Single-name and event risk: A relatively small number of issuers can account for a large share of the U.S. equity sleeve. Company-specific events—earnings inflections, product or clinical milestones, competitive shocks, regulatory actions or M&A—can lead to sizable moves in the synthetic capital trajectory. - Liquidity and lock-up dynamics: Many holdings originate from IPOs or de-SPAC transactions and may be subject to lock-up restrictions or thin liquidity early in their public lifecycle, amplifying volatility during sector-wide sell-offs or macro shocks. Form 13F does not disclose private investments, non-U.S. securities, or any hedging or overlay strategies that SVB Capital Management, LLC may employ at the fund level. A holdings-based reconstruction that links positions across filings and assumes they are held between quarter-ends (subject to observed additions and sales) therefore provides a synthetic long-only view that generally overstates directional equity risk relative to fund-level positioning. Nonetheless, by feeding the 13F record into analytics, one can estimate the U.S. sleeve’s Volatility Profile on a normalized notional basis, highlighting how variable these venture-backed public holdings have been across periods of abundant liquidity versus tighter funding, growth-stock rallies versus valuation compressions, and shifting sentiment toward technology and healthcare.